Ligand Pharmaceuticals | LGND - Le Revenu D'Intérêts





Le Revenu D'Intérêts Changement Date
Arrowhead Research USD 16.93M 66K 2026-06
Baxter International USD 12M 1000K 2026-03
Eli Lilly USD 65M 25M 2025-09
Enviri Corporation USD -1.05 0.89 2024-12
Gilead Sciences USD 95M 0 2026-03
GlaxoSmithKline GBP 22M 96M 2026-03
Glaxosmithkline GBP 22M 4M 2026-03
Heron Therapeutics USD 433K 277K 2021-12
Insmed USD 765K 55K 2024-09
Intrexon USD 319K 602K 2024-06
Ionis Pharmaceuticals USD -0.66 0.29 2024-12
Karyopharm Therapeutics USD -0.15 0.11 2024-12
Ligand Pharmaceuticals USD 6.65M 262K 2026-03
MacroGenics USD 1.55M 26K 2026-03
Merck USD 35M 34M 2026-03
Pacira USD 1.93M 365K 2026-03
Pfizer USD -0.04 115M 2026-06
Rigel Pharmaceuticals USD 0.7 0.76 2024-09
Veracyte USD 3.48M 4K 2026-03